Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge
Authors:
- Soko SetoguchiSSSoko Setoguchi
- Robert J. GlynnRGRobert J. Glynn
- Jerry AvornJAJerry Avorn
- Murray A. MittlemanMMMurray A. Mittleman
- Raisa LevinRLRaisa Levin
- Wolfgang C. WinkelmayerWWWolfgang C. Winkelmayer
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary preventionBMJ, 2005
- Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997Circulation, 2001
- Cost effectiveness of ramipril treatment for cardiovascular risk reductionHeart, 2001
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJAMA, 2001
- Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populationsThe Lancet, 2000
- Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994New England Journal of Medicine, 1998
- Improved Outcome of Elderly Patients (≥75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in IsraelCirculation, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionNew England Journal of Medicine, 1988